Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study
Keyword(s):
Keyword(s):
2013 ◽
2017 ◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 506-506
◽
Keyword(s):